TE_137
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | MLT1O |
|---|---|
| TE superfamily | MaLR |
| TE class | LTR |
| Gene | - |
| Class | Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 0.32 |
| Counts of samples | TCGA_tumor:178; TCGA_normal:11; GTEx:628 |
| TSS | chr1(-):15485633 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_137.1 | - | Intergenic | Non-coding | Non-coding | chr1(-):15464852,15464872,15467140,15467290,15484625,15484774,15485541,15485634 |
| teRNA_137.2 | - | Intergenic | Non-coding | Non-coding | chr1(-):15464852,15464872,15467140,15467290,15484502,15484774,15485541,15485634 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
